[Granulomatous lymphocytic interstitial lung disease (GLILD) as a manifestation of pulmonary changes in common variable immunodeficiency (CVID) – case report].
Elżbieta Marciszewska, Anna Szaflarska, Anna Pituch-Noworolska
{"title":"[Granulomatous lymphocytic interstitial lung disease (GLILD) as a manifestation of pulmonary changes in common variable immunodeficiency (CVID) – case report].","authors":"Elżbieta Marciszewska, Anna Szaflarska, Anna Pituch-Noworolska","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Common variable immunodeficiency\n(CVID) comprise different kinds of\nprimary hypogammaglobulinemias of\nmostly unknown etiology. The onset of\nthe disease and its clinical symptoms\nmay appear as well in children as in\nadults. Apart from susceptibility to\nbacterial, viral and fungal infections,\nother clinical signs (autoimmunization,\nnon-infectious lung and gastrointestinal\ndiseases, neoplasm) are frequently\nobserved. About 58% of patients with\nCVID develops granulomatous and\nlymphocytic interstitial lung disease\n(GLILD) associated with early mortality.</p>","PeriodicalId":21148,"journal":{"name":"Przeglad lekarski","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad lekarski","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Common variable immunodeficiency
(CVID) comprise different kinds of
primary hypogammaglobulinemias of
mostly unknown etiology. The onset of
the disease and its clinical symptoms
may appear as well in children as in
adults. Apart from susceptibility to
bacterial, viral and fungal infections,
other clinical signs (autoimmunization,
non-infectious lung and gastrointestinal
diseases, neoplasm) are frequently
observed. About 58% of patients with
CVID develops granulomatous and
lymphocytic interstitial lung disease
(GLILD) associated with early mortality.